Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Survival statistics for pancreatic cancer are outrageous according to cancer charity

A three-year study recently revealed the €œoutrageous€ five-year survival of the most common type of pancreatic cancer – pancreatic ductal adenocarcinoma (PDAC). 

A three-year study recently revealed the €œoutrageous€ five-year survival of the most common type of pancreatic cancer – pancreatic ductal adenocarcinoma (PDAC).  The research, commissioned by Pancreatic Cancer UK and carried out by the London School of Hygiene & Tropical Medicine, found that in England, just 3% of people with pancreatic ductal adenocarcinoma (PDAC) will live for five years or more; compared with a ten times higher five-year survival (34%) for patients with another type called pancreatic neuroendocrine tumours or PNET. Although 95% of people with pancreatic cancer are diagnosed with PDAC, survival data has previously been published together with PNET. This has

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy